Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 705 | 1,731 | 2,950 | 492 | 0 |
| Gross Profit | 705 | 1,731 | 2,950 | 492 | N/A |
| Operating Expenses | 38,535 | 16,705 | 4,138 | 863 | 14,487 |
| Operating Income | -37,830 | -14,974 | -1,188 | -371 | -14,487 |
| Interest Expense | 319 | 152 | 0 | 0 | 845 |
| Other Income | 1,296 | 7,143 | 22 | 2 | 674 |
| Pre-tax Income | -36,853 | -7,983 | -1,166 | -369 | -14,658 |
| Income Tax | -366 | -200 | 66 | N/A | N/A |
| Net Income Continuous | -36,487 | -7,783 | -1,232 | -369 | -14,658 |
| Net Income | $-36,487 | $-7,783 | $-1,232 | $-369 | $-14,658 |
| EPS Basic Total Ops | -2.63 | -1.20 | -2.18 | -0.74 | -81.08 |
| EPS Basic Continuous Ops | -2.63 | -1.20 | -2.18 | -0.74 | -81.10 |
| EPS Diluted Total Ops | -2.63 | -1.20 | -2.18 | -0.74 | -81.08 |
| EPS Diluted Continuous Ops | -2.63 | -1.20 | -2.18 | -0.74 | -81.10 |
| EPS Diluted Before Non-Recurring Items | -2.63 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-38,111 | $-14,733 | $-1,119 | $-370 | $-13,691 |